Shanghai Allist Pharmaceuticals Co. Ltd. Class ASSE: 688578

"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026

Jul 17, 2026 · Issued by Shanghai Allist Pharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shanghai Allist Pharmaceuticals Co. Ltd. Class A

"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Abnormal Fluctuations in Stock TradingJul 4
Announcement on Implementation of Dividend Distribution for 2025May 26
Announcement on Resolutions of the 2025 Annual General MeetingMay 14
Announcement on Voluntary Disclosure of Obtaining of Approval Notice for the Drug Clinical Trial of Newly Approved Indication of Furmonertinib Mesylate TabletsApr 30

All Shanghai Allist Pharmaceuticals Co. Ltd. Class A news releases